MEDI-557 Adult Dosing

NCT01562938 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus

Interventions

DRUG: Placebo
DRUG: MEDI-557
DRUG: MEDI-557

Sponsor

MedImmune LLC